These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31081025)

  • 1. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.
    Konrad L; Andersen K; Kesper MS; Kumar SV; Mulay SR; Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):86-97. PubMed ID: 31081025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.
    Marschner JA; Mulay SR; Steiger S; Anguiano L; Zhao Z; Boor P; Rahimi K; Inforzato A; Garlanda C; Mantovani A; Anders HJ
    Front Immunol; 2018; 9():2173. PubMed ID: 30319631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
    Andersen K; Kesper MS; Marschner JA; Konrad L; Ryu M; Kumar Vr S; Kulkarni OP; Mulay SR; Romoli S; Demleitner J; Schiller P; Dietrich A; Müller S; Gross O; Ruscheweyh HJ; Huson DH; Stecher B; Anders HJ
    J Am Soc Nephrol; 2017 Jan; 28(1):76-83. PubMed ID: 27151924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Background but Not Intestinal Microbiota After Co-Housing Determines Hyperoxaluria-Related Nephrocalcinosis in Common Inbred Mouse Strains.
    Ma Q; Grigorescu M; Schreiber A; Kettritz R; Lindenmeyer M; Anders HJ; Steiger S
    Front Immunol; 2021; 12():673423. PubMed ID: 33968083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease.
    Yang J; Lim SY; Ko YS; Lee HY; Oh SW; Kim MG; Cho WY; Jo SK
    Nephrol Dial Transplant; 2019 Mar; 34(3):419-428. PubMed ID: 29939312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.
    Mulay SR; Eberhard JN; Desai J; Marschner JA; Kumar SV; Weidenbusch M; Grigorescu M; Lech M; Eltrich N; Müller L; Hans W; Hrabě de Angelis M; Vielhauer V; Hoppe B; Asplin J; Burzlaff N; Herrmann M; Evan A; Anders HJ
    J Am Soc Nephrol; 2017 Mar; 28(3):761-768. PubMed ID: 27612997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of Hyperoxaluria and Kidney Disease after Combined Intestine-Kidney Transplantation for Enteric Hyperoxaluria.
    Ekser B; Mangus RS; Kubal CA; Fridell JA; Powelson JA; Nagaraju S; Mihaylov P; Phillips CL; Saxena R; Goggins WC
    Am J Nephrol; 2016; 44(2):85-91. PubMed ID: 27410399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Anders HJ; Suarez-Alvarez B; Grigorescu M; Foresto-Neto O; Steiger S; Desai J; Marschner JA; Honarpisheh M; Shi C; Jordan J; Müller L; Burzlaff N; Bäuerle T; Mulay SR
    Kidney Int; 2018 Mar; 93(3):656-669. PubMed ID: 29241624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice.
    Watanabe IKM; Andrade-Silva M; Foresto-Neto O; Felizardo RJF; Matheus MAC; Silva RC; Cenedeze MA; Honda TSB; Perandini LAB; Volpini RA; Pacheco-Silva A; Câmara NOS
    Front Immunol; 2020; 11():578623. PubMed ID: 33414781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2019 Update in basic kidney research: microbiota in chronic kidney disease, controlling autoimmunity, kidney inflammation and modelling the glomerular filtration barrier.
    Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):4-9. PubMed ID: 31943087
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity.
    Efe O; Verma A; Waikar SS
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):316-320. PubMed ID: 31045662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Provides Protection against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Intestinal Barrier Dysfunction, and Liver Inflammation.
    Xiao J; Zhang R; Zhou Q; Liu L; Huang F; Deng Y; Ma Y; Wei Z; Tang X; Zhang M
    J Agric Food Chem; 2017 Nov; 65(44):9675-9684. PubMed ID: 29041775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Link between gut microbiota dysbiosis and chronic kidney disease.
    Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.